Ling 2019 Cell Metab

From Bioblast
Revision as of 11:36, 24 June 2019 by Gnaiger Erich (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Publications in the MiPMap
Ling C, Rönn T (2019) Epigenetics in human obesity and type 2 diabetes. Cell Metab 29:1028-44. https://doi.org/10.1016/j.cmet.2019.03.009.

» PMID: 30982733 Open Access

Ling C, Roenn T (2019) Cell Metab

Abstract: Epigenetic mechanisms control gene activity and the development of an organism. The epigenome includes DNA methylation, histone modifications, and RNA-mediated processes, and disruption of this balance may cause several pathologies and contribute to obesity and type 2 diabetes (T2D). This Review summarizes epigenetic signatures obtained from human tissues of relevance for metabolism-i.e., adipose tissue, skeletal muscle, pancreatic islets, liver, and blood-in relation to obesity and T2D. Although this research field is still young, these comprehensive data support not only a role for epigenetics in disease development, but also epigenetic alterations as a response to disease. Genetic predisposition, as well as aging, contribute to epigenetic variability, and several environmental factors, including exercise and diet, further interact with the human epigenome. The reversible nature of epigenetic modifications holds promise for future therapeutic strategies in obesity and T2D.

Copyright © 2019 Elsevier Inc. All rights reserved.


Bioblast editor: Gnaiger E


Labels: MiParea: mtDNA;mt-genetics, nDNA;cell genetics, Comparative MiP;environmental MiP, Gender, Exercise physiology;nutrition;life style, mt-Medicine  Pathology: Aging;senescence, Diabetes 

Organism: Human  Tissue;cell: Skeletal muscle, Liver, Islet cell;pancreas;thymus, Blood cells, Fat